Difference between revisions of "Moullan Norman"
From Bioblast
(Created page with "{{Person |lastname=Moullan |firstname=Norman |title=Lab manager |institution=Laboratory of Integrative & Systems Physiology (LISP) Nestle Chair in Energy Metabolism (NCEM) Ec...") ย |
m (Gnaiger Erich moved page Moullan N to Moullan Norman over redirect) ย |
||
(One intermediate revision by the same user not shown) | |||
Line 15: | Line 15: | ||
|country=Switzerland | |country=Switzerland | ||
|weblink=http://auwerx-lab.epfl.ch | |||
}} | }} | ||
{{Labelingperson | {{Labelingperson | ||
|field of research=Basic | |field of research=Basic | ||
}} | }} |
Latest revision as of 03:48, 1 March 2020
Name | Moullan Norman, Lab manager |
---|---|
Institution | Laboratory of Integrative & Systems Physiology (LISP)
Nestle Chair in Energy Metabolism (NCEM) Ecole Polytechnique Federale de Lausanne (EPFL) |
Address | AI 1351
SV/IBI1/LISP/NCEM, Station 15, CH-1015 |
City | Lausanne |
State/Province | |
Country | Switzerland |
[email protected] | |
Weblink | http://auwerx-lab.epfl.ch |
O2k-Network Lab | CH Lausanne Auwerx J |
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
Gariani 2016 Hepatology | 2016 | Gariani K, Menzies KJ, Ryu D, Wegner CJ, Wang X, Ropelle ER, Moullan N, Zhang H, Perino A, Lemos V, Kim B, Park YK, Piersigilli A, Pham TX, Yang Y, Ku SC, Koo SI, Fomitchova A, Cantรณ C, Schoonjans K, Sauve AA, Lee JY, Auwerx J (2016) Eliciting the mitochondrial unfolded protein response via NAD+ repletion reverses fatty liver disease. Hepatology 63:1190-204. |
Bonhoure 2015 Genes Dev | 2015 | Bonhoure N, Byrnes A, Moir RD, Hodroj W, Preitner F, Praz V, Marcelin G, Chua SC Jr, Martinez-Lopez N, Singh R, Moullan N, Auwerx J, Willemin G, Shah H, Hartil K, Vaitheesvaran B, Kurland I, Hernandez N, Willis IM1 (2015) Loss of the RNA polymerase III repressor MAF1 confers obesity resistance. Genes Dev 29:934-47. |
Van de Weijer 2015 Diabetes | 2015 | van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, Livingstone R, Nowotny P, Sparks LM, Paglialunga S, Szendroedi J, Havekes B, Moullan N, Pirinen E, Hwang JH, Schrauwen-Hinderling VB, Hesselink MK, Auwerx J, Roden M, Schrauwen P (2015) Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64:1193-201. |